학술논문
Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19
Document Type
Article
Author
Mao, L.; Jin, C.; Kushnareva, Y.; Liu, J.; Zhu, Z.; Kotoi, O.; Chumakova, L.; Xu, X.; Shaabani, N.; Powers, C.; Stegman, K.; Xie, H.; Kerwin, L.; Royal, M.; Brunswick, M.; Allen, R.; Ji, H.; Zhang, X.; Xu, W.; Xu, C.; Bao, Y.; Xu, L.; Zhang, Y.; Yang, H.; Qian, S.; Hu, Y.; Shao, J.; Zhang, C.; Li, T.; Li, Y.; Liu, N.; Lin, Z.; Wang, S.; Wang, C.; Shen, W.; Argent, C.; Lin, Y.; Shu, D.; Lu, H.; Han, Q.; Teijaro, J.
Source
In: Med . (Med, 12 January 2024, 5(1):42-61.e23)
Subject
Language
English
ISSN
26666340
26666359
26666359